Clinical Trials Browser

Phase 2 × NETWORK × carfilzomib × Clear all

NCT01903811 2024-12-20

S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma

Phase 2 Completed

143 enrolled 14 charts

Multiple Myeloma, Recurrence

NCT01346787 2023-09-08

CCD

Phase 2 Completed

Multiple Myeloma

NCT02597062 2023-08-28

High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma

Phase 2 Completed

76 enrolled 9 charts

Multiple Myeloma